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The aqueous and 50% methanolic extracts of leaf of Morinda lucida were investigated for their 
phytochemical constituents, hypoglycemic and toxicological effects in alloxan-induced hyperglycemia 
in rats. In addition, the possible acute toxicological effects of the extracts were also studied for seven 
days.The results revealed the presence of alkaloids, cardenolides, flavonoids, glycosides, saponins and 
steroids in the aqueous extract while 50% methanolic extract contained anthraquinones in addition to 
those found in aqueous extract. Phenolics and tannins were not detected in both extracts while 
anthraquinones was not detected in aqueous extract. The extracts significantly (P<0.05) lowered the 
blood glucose level in the alloxan-induced hyperglycemia in rats. However, the aqueous extract was 
more effective than the 50% methanolic extract, though they may possibly be toxic at the doses used 
because marker enzymes (ALP, AST and ALT) were secreted into the sera of these extracts-treated rats. 
The acute intra-peritoneal toxicity study of the extracts at the limit doses of 500-1500 mg/kg body weight 
revealed toxicity of the extracts, most especially at relatively high concentrations for seven days.   
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INTRODUCTION 
 
Hyperglycemia is a serious health condition that can also 
be referred to as diabetes mellitus or ‘Sugar diabetes’ as 
it is often called by lay people. Chronic disorder of 
carbohydrate, lipid and protein metabolism, characterised 
by persistent elevation of fasting blood glucose level 
above 200 mg/dl, due to insufficient or complete 
cessation of insulin synthesis or secretion and/or 
peripheral resistance to insulin action may lead to 
hyperglycemia (Murray and Pizzorno, 1997, Odutuga et 
al., 2010). It is associated with increased risk of heart 
disease, stroke, kidney disease, retinopathy, neuropathy, 
ulceration and gangrene of extremities (Rotshteyn and 
Zito, 2004). Thus, diabetes mellitus and its associated 
complications have significant impact on health, quality of 
life and life expectancy of its sufferers. The global 
epidemic of diabetes mellitus is worse or greater in 
developing than the developed countries (Rotshteyn and 
Zito, 2004).  
 
 
 
*Corresponding author email: bafiab@yahoo.com. 
   In response to this global health challenge, the World 
Health Organisation (WHO) expert committee on 
diabetes mellitus recommended further evaluation of the 
methods of managing the disease because of high 
mortality and morbidity arising from its complications and 
draw backs associated with the use of conventional 
antidiabetic drugs (Adeneye, et al., 2006). There is a 
broad therapeutic fight against diabetes, but 
unfortunately, there is no particular cure for it; the disease 
has only been managed.    
In order to meet up with this challenge, there is urgent 
need to double the herbal therapeutic efforts aimed at 
selecting remedies for diabetes mellitus. In pursuit of this 
goal, several medicinal plants are being investigated for 
their antidiabetic efficacies. Of the several indigenous 
plants used in the local treatment of diabetes mellitus 
include the extracts of Sarsaparilla (Augusti and Mathew, 
1973), Beta vulgaris (Yoshikawa et al., 1996), Aloe 
barbadensis (Al-Awadi and Gumaa, 1997; Grover et al., 
2001) and Morinda lucida. 
Morinda lucida benth (Rubiaceae) is a tropical West 
Africa rainforest tree also called Brimestone tree while  
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among the Yoruba natives, it is called ‘Oruwo’ (Adesida 
and Adesogan, 1972; Odutuga et al., 2010). Different 
parts of the plant are attributed with diverse therapeutic 
benefits. For instance, in Southern Cameroon, cold 
decoction of the plant’s leaves is used for the treatment 
of fever (Adesida and Adesogan, 1972). However, in 
most parts of West Africa, the bitter water decoction of 
the stem bark of the plant, root and leaf are used as bitter 
tonic and as stringent for dysentery, abdominal colic and 
intestinal worm infestation (Adesida and Adesogan, 1972, 
Odutuga et al., 2010). The Europeans sometimes use the 
decoction of the plant root or stem to make “bitters” 
(Adesida and Adesogan, 1972). Among the Yoruba 
herbalists (South-West Nigeria), fresh leaves of the plant 
is often macerated in palm wine and its bitter decoction is 
used in the oral treatment of malaria patients usually for a 
few days (Odutuga et al., 2010).  
In the present study, the aqueous and 50% methanolic 
leaf extracts of Morinda lucida were investigated for their 
hypoglycemic activity and acute toxicological effects on 
some important organs of albino rats.     
 
 
MATERIALS AND METHODS 
 
Plant material 
 
Morinda lucida leaves were obtained at Ikeji-Arakeji 
Village, Osun State, Nigeria. The plant was identified at 
the Department of Biological Sciences, Joseph Ayo 
Babalola University, Ikeji-Arakeji, Nigeria. 
 
 
Animals 
 
The albino rats (Rattus norvegicus) used for this study 
were obtained from the Animal House, Department of 
Biochemistry, College of Natural Sciences, Joseph Ayo 
Babalola University, Ikeji-Arakeji, Nigeria. 
 
 
Assay Kits 
 
Alkaline phosphatase (ALP), Aspartate aminotransferase 
(AST) and Alanine aminotranferase (ALT) were products 
of Randox Laboratories Limited, UK. 
 
 
Chemicals and Reagents 
 
Alloxan monohydrate was a product of Mekphar 
Chemical Pharmaceutical Joint-Stock Company, Chiminh 
City, Vietnam. All other reagents used were of analytical 
grade and obtained from BDH, London. 
 
 
 
Preparation of extracts 
 
Morinda lucida leaves were air-dried for 2 weeks and 
milled to powdered form using milling Machine. The 
powder (500 g each) was soaked in 1 litre of aqueous 
and 50% methanol respectively for 24 hours and then 
filtered with Muslin cloth. The filterate obtained from both 
extracts were completely dried into powder over a boiling 
water-bath. The residue obtained from the aqueous and 
methanolic leaf extracts were stored separately in water- 
and air-proof containers and kept in the refrigerator until 
when needed for analysis. 
 
 
Phytochemical Screening 
 
Qualitative phytochemical analysis of aqueous and 50% 
methanolic leaf extracts was carried out with the method 
described by Odebiyi and Sofowora (1978). 
 
 
Induction of diabetes in rats 
 
A single intra-peritoneal (ip) injection of 1 ml of 150 mg/kg 
body weight of Alloxan monohydrate dissolved in 0.1M 
freshly prepared cold Citrate buffer of pH of 3.0 was 
injected into each rat (Pari and Venkateswaran, 2002). 
Stable hyperglycemia was confirmed on the 5th day using 
glucometer. Rats with fasting blood glucose level greater 
than 200 mg/dl were considered hyperglycemic and used 
for this study. 
 
 
Experimental design for hyperglycemic activity of the 
leaf extracts of Morinda lucida  
 
Fourty albino rats (Rattus norvegicus) weighing between 
140-145 g each were used for the experiments. 
Twenty rats were divided into four groups (A-D) of five 
rats each for the aqueous extract. Group A consists of 
control rats, which are not hyperglycemic but given 1 ml 
of distilled water while group B consist untreated alloxan-
induced hyperglycemic rats. Groups C and D consist of 
the alloxan-induced hyperglycemic rats treated with 120 
and 240 mg/kg body weight of aqueous respectively.  
The remaining twenty rats were divided into four groups 
(A-D) of five rats each for 50% methanolic extract. 
Groups A and B were treated as in aqueous extract while 
groups C and D were also treated with 120 and 240 
mg/kg body weight of 50% methanolic extract 
respectively.  
 
 
Preparation of serum  
 
Rats in each group were starved overnight but had  
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                              Table 1 Phytochemical constituents of leaf aqueous and methanolic extracts of Morinda lucida 
 
Phytochemical constituents Extracts of leaf of Morinda lucida  
Aqueous Methanolic 
Alkaloids  + + 
Anthraquinones  - + 
Cardenolides  + + 
Flavonoids + + 
Glycosides  + + 
Phenolics  - - 
Saponins  + + 
Steroids  + + 
Tannins  - - 
                                + = present 
                               -  = Absent 
 
 
access to water ad libitum, weighed and sacrificed by 
cervical dislocation while under mild anesthesia. Blood (2 
ml) was collected from each rat by cardiac puncture into 
plain tube. The blood was left undisturbed for 5 minutes 
and then centrifuged at 3500 rpm (Beckman GS-6R, 
Germany) for 10 minutes at 40C. The supernatant 
(serum) was collected and used for measuring fasting 
blood glucose level and enzymes (AST, ALP and ALT) 
activities. 
 
 
Preparation of tissue homogenate 
 
Rats were anesthetised and their liver and kidney were 
quickly excised, rinsed in isotonic sterile saline and 
blotted dry on a tissue paper before weighing. A portion 
of each liver and kidney was cut out, weighed and 
chopped into small pieces and then homogenised with 
pre-cooled pestle and mortar in a bowl of ice cubes. Each 
tissue homogenate was then placed in a separate plastic 
containing ice-cold isotonic sterile saline and stored at -
40C for further analysis.    
 
 
Enzyme assay 
 
The procedure described by Reitman and Frankel (1957) 
was employed for the assay of aspartate 
aminotransferase (EF 2.6.1.1) and alanine 
aminotranferase (EC 2.6.1.2) activities while the 
procedure described in the assay kit of alkaline 
phosphatase was used.  
 
Acute toxicity studies 
 
Fourty rats were also used for the experiment. For the 
aqueous extract, twenty rats were divided into four 
groups (A-D) of five rats each. Groups A-D were 
administered 0, 500, 1000 and 1500 mg/kg body weight 
of aqueous leaf extract of Morinda lucida. Similarly, this 
was repeated for 50% methanolic leaf extract of Morinda 
lucida. The acute toxicological effects of the two extracts 
with these concentrations on rats were studied for seven 
days. 
 
 
Statistical analysis 
 
Data were expressed as means ± S.D of five 
determinations. Data were subjected to statistical 
analysis using one-way analysis of variance (ANOVA) 
and Duncan Multiple Range Test. Differences were 
considered statistically significant at P < 0.05.   
 
RESULTS 
 
Of the phytochemicals investigated, alkaloids, 
cardenolides, flavonoids, glycosides, saponins and 
steroids are present in the aqueous extract while 50% 
methanolic extract contained anthraquinones in addition. 
Phenolics and tannins were not detected in both extracts 
(Table 1). 
The aqueous and 50% methanolic extracts significantly 
(P<0.05) reduced the blood glucose level of the 
hyperglycemic treated rats compares with the untreated 
group. The hypoglycemic activities of the extracts are 
concentration dependent. This is evident in the blood 
glucose level of the hyperglycemic animals (group D) 
treated with 240 mg/kg body weight of both extracts, 
which were significantly (P<0.05) reduced compared with 
those hyperglycemic animals (group C) treated with 120 
mg/kg body weight of the extracts. However, the aqueous 
extract showed more hypoglycemic effects compared 
with the 50% methanolic extract (Table 2).    
  There was a significant (P<0.05) decrease in the final 
body weights of both extracts-treated and untreated 
hyperglycemic rats (groups B, C and D) compared with 
the control (group A). However, the final body weights of  
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                           Table 2  Hypoglycemic activities of leaf extracts of Morinda lucida on rats 
 
Animal groups  Blood glucose level (mg/dl) 
Aqueous extract Methanolic extract 
Initial Final Initial Final 
A 118.00 ± 1.01 118.00 ± 1.30a 118.00 ± 1.01 118.00 ± 1.30a 
B 220.00 ± 2.70 236.00 ± 3.30d 220.00 ± 2.70 236.00 ± 3.30d 
C 235.00 ± 0.78 134.00 ± 2.40c 244.00 ± 2.60 169.50 ± 1.10c 
D 239.00 ± 2.90 76.00 ± 1.80b 248.00 ± 1.60 78.00 ± 1.20b 
      
                       Values are mean of five determinations + SD 
 
 
 
 
                           Table 3  Effects of leaf extracts of Morinda lucida on weight of rats   
 
Animal groups  Body weight (g) 
Aqueous extract Methanolic extract 
Initial Final Initial Final 
A 140.50 ± 3.24 149.00 ± 3.26a 140.50 ± 3.24 149.00 ± 3.26a 
B 140.50 ± 2.90 125.80 ± 2.60d 140.50 ± 2.90 125.80 ± 2.60d 
C 141.70 ± 2.70 149.50 ± 1.20b 142.05 ± 1.15 148.35 ± 2.90b 
D 143.00 ± 1.40 147.30 ± 3.50c 139.85 ± 1.80 144.90 ± 2.00c 
      
                        Values are mean of five determinations + SD 
 
 
 
 
    Table 4  Effects of leaf extracts of Morinda lucida on alkaline phosphatase activity 
 
Animal groups  Alkaline phosphatase activity (nm/min./mg/protein) 
Aqueous extract Methanolic extract 
Serum  Liver Kidney  Serum  Liver Kidney  
A 515.20 ± 0.10a 991.63 ± 0.60a 655.04 ± 0.30a 515.20 ± 0.10a 991.63 ± 0.60a 655.04 ± 0.30a 
B 581.97 ± 0.70e  396.96 ± 0.10d 506.92 ± 0.70e 581.97 ± 0.70d  396.96 ± 0.10d 506.92 ± 0.70d 
C 520.07 ± 0.50b  496.01 ± 0.70c 634.34 ± 0.60c 517.98 ± 0.20b 976.64 ± 0.90b 648.11 ± 0.20b 
D 527.35 ± 0.50c 615.11 ± 0.30b 644.21 ± 0.30b 519.25 ± 0.60c 842.49 ± 0.50c 633.70 ± 0.10c 
    Values are mean of five determinations + SD 
 
 
the extracts-treated hyperglycemic rats (C and D) were 
significantly (P<0.05) increased compared with the 
untreated hyperglycemic rats (Group B). Furthermore, 
there was a significant reduction in the final body weights 
of the hyperglycemic rats treated with 50% methanolic 
extract compared with those treated with the aqueous 
extract (Table 3).  
The activities of ALP in the serum of the untreated and 
extracts-treated hyperglycemic rats were significantly 
(P<0.05) increased compared with the control. Also, the 
activities of ALP in the liver and  kidney  of  the  untreated  
 
 
 
and extracts-treated hyperglycemic rats were significantly 
(P<0.05) reduced compared with the control (Table 4).  
A significant increase (P<0.05) in the activities of AST 
in the serum of extracts-treated rats (groups C and D) 
was observed compared with the hyperglycemic -
untreated group (group B) and control (group A). 
However, there was a significant reduction in the 
activities of AST in the liver and kidney of hyperglycemic -
untreated and extracts-treated rats compared with the 
control (Table 5).  
Furthermore, there  was  a  significant  increase  in  the  
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Table 5  Effects of leaf extracts of Morinda lucida on aspartate aminotransferase activity 
 
Animal groups  Aspartate aminotransferase activity (nm/min./mg/protein) 
Aqueous extract Methanolic extract 
Serum  Liver Kidney  Serum  Liver Kidney  
A 48.47 ± 0.40a 50.47 ± 0.30a 41.70 ± 0.50a 48.47 ± 0.40a 50.47 ± 0.30a 41.70 ± 0.50a 
B 61.03 ± 0.00e 38.23 ± 0.60d 33.03 ± 0.40e 61.03 ± 0.00d 38.23 ± 0.60d 33.03 ± 0.40c 
C 48.83 ± 0.80b 46.50 ± 0.40b 40.87 ± 0.10b 49.27 ± 0.30b 40.30 ± 0.10c 41.27 ± 0.10b 
D 49.53 ± 0.40c 45.43 ± 0.60c 39.80 ± 0.60c 49.33 ± 0.70c 47.97 ± 0.80b 41.60 ± 0.80a 
Values are mean of five determinations + SD 
 
 
Table 6  Effects of leaf extracts of Morinda lucida on alanine aminotransferase activity 
 
Animal groups  Alanine aminotransferase activity (nm/min./mg/protein) 
Aqueous extract Methanolic extract 
Serum  Liver Kidney  Serum  Liver Kidney  
A 10.97 ± 0.20a 71.87 ± 0.40a 42.47 ± 0.20a 10.97 ± 0.20a 71.87 ± 0.40a 42.47 ± 0.20a 
B 15.27 ± 0.80b 81.97 ± 0.40e 56.13 ± 0.60c 15.27 ± 0.80c 81.97 ± 0.40e 56.13 ± 0.60d 
C 16.00 ± 0.60c 78.70 ± 0.40c 45.87 ± 0.60b 16.03 ± 0.20d 59.60 ± 0.70b 34.17 ± 0.60b 
D 16.23 ± 0.10d 81.70 ± 0.00d 79.37 ± 0.00e 17.10 ± 0.10e 68.07 ± 0.00c 79.37 ± 0.00e 
   Values are mean of five determinations + SD 
 
 
activities of ALT in the serum, liver and kidney of the 
untreated and extracts-treated hyperglycemic rats except 
in the kidney of those rats treated with 120 mg/kg body 
weights of 50% methanolic extract when compared with 
the control (Table 6). 
         The results from acute toxicological studies 
revealed that the control rats were very healthy and 
active while those administered with 500, 1000 and 1500 
mg/kg body weight of the aqueous extract were weak and 
lost appetite but no mortality was recorded throughout the 
experimental period.  
           Although there was no mortality recorded with the 
administration of 500 mg/kg body weight of 50% 
methanolic extract throughout the experimental period, 
but the animals were weak. However, the animals 
administered with 1000 mg/kg body weight of 50% 
methanolic extract started to die on the third day while all 
the rats administered with 1500 mg/kg body weight died 
within 4½ hours. The last rat of the group that was 
administered with 1500 mg/kg body weight of 50% 
methanolic extract died after four hours of administration 
(Table 7). 
  
DISCUSSION 
 
Scientists in the area of phytomedicine and toxicology are 
now interested in herbal medicine in developing countries 
(Obici, et al., 2008). Herbal treatments involve mainly the 
use of plant extracts and other plant products (Akerele, 
1993; Saggu, et al., 2007), which contain bioactive 
substances that may have potentials to prevent or cause  
adverse effects (Bent and Ko, 2004). The results of 
phytochemical screening obtained  from  extracts  of   this  
study agree with those previously reported by Ogundare 
and Onifade, (2009) and Patience et al., (2010).  One or 
more of these phytoconstituents present in the leaf 
extracts of Morinda lucida might be responsible singly or 
in combination for its observed hypoglycemic effects in 
the alloxan-induced hyperglycemia in rats. However, the 
higher potency demonstrated by aqueous extract as 
observed in this study may be due to the amount/quantity 
of phytochemicals responsible for the hypoglycemic 
activity in the aqueous extract since the same 
concentrations of the extracts were administered. 
Observations of hypoglycemic activities of these extracts 
agree with the previous work carried out with the stem 
bark of the same plant (Odutuga et al., 2010). The 
mechanism of action of the extracts may possibly be by 
increasing the effects of insulin, either by increasing the 
secretion of insulin from pancreas in the cells of islet of 
Langerhans or its release from bound insulin (Pari and 
Amarnah,   2004;   Odutuga    et al., 2010).  
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     Table 7  Acute toxicity effects of leaf extracts of Morinda lucida on rats 
 
  Animal groups Aqueous extract Methanolic extract  
Observation  Mortality  Observation  Mortality  
A The animals were healthy 
and active throughout the 
experimental period 
No death throughout the 
experimental period of 
seven days  
The animals were healthy and 
active throughout the 
experimental period 
No death  
 
B 
The animals were weak for 
about one hour and became 
active again 
No death throughout the 
experimental period of 
seven days  
The animals were weak for 
about 12 hours  
No death but lost 
appetite throughout the 
experimental period of 
seven days    
 
 
C 
The animals were weak and 
lost appetite for about six 
hours and became active 
again 
No death throughout the 
experimental period of 
seven days 
The animals were weak for 
about two days 
They started to die on 
the third day 
 
 
D 
The animals were weak and  
lost appetite for about 24 
hours and became active 
again 
No death throughout the 
experimental period of 
seven days  
The animals were immediately 
weak  
They all died after four 
hours 
 
The measurement of the activities of 
various enzymes in tissues and body fluids 
play a significant and well known aid in 
disease investigation and diagnosis 
(Malomo, 2000; Yakubu et al., 2003). ALP is 
a marker enzyme for the plasma membrane 
and endoplasmic reticulum (Shahjahan et al., 
2004) and often employed to assess the 
integrity of the plasma membrane (Akanji et 
al., 1993). The observed reduction in ALP 
activities in the liver and kidney following the 
administration of the extracts may limit or 
hinder the adequate transportation of the 
required ions on the molecules across the 
plasma membrane (Akanji et al., 1993). It 
may also lead to the less availability of the 
phosphate groups for the phosphorylation of 
ethanolamine and choline needed for the 
synthesis of major phospholipids like 
phosphatidylethanolamine and 
phosphatidylcholine. Furthermore, it can also 
hinder the synthesis of nuclear acids 
(Ramalingam and Vimaladevi, 2002).  AST 
and ALT are also useful marker enzymes in 
assessing damage to organs. They are 
normally localised within the cells of the liver, 
kidney, and some other organs. These 
enzymes are released into the serum 
especially when there is damage to the 
hepatic membrane as a result of chemical 
assaults. 
 Serum levels of these enzymes 
therefore are significant diagnostic tools in 
assessing the level of hepatic damage 
(Oluba et al., 2008; Odutuga et al., 2010). 
Therefore, their presence in the serum of the 
extracts-treated animals may be given 
information on the tissue injury or 
dysfunction. 
The study of acute toxicity revealed that 
the extracts are very toxic at relatively high 
concentrations. Methanolic extract may be 
more toxic than aqueous extract because 
mortality was recorded in the methanolic 
  
 
 
 
extract-treated rats but not  with the aqueous extract. 
 
 
CONCLUSION 
 
This study revealed that the leaf aqueous and methanolic 
extracts of Morinda lucida have hypoglycemic effects on 
alloxan-induced hyperglycemia in albino rats. However, 
the doses of the extracts used may be toxic. The 
methanolic extract may be more toxic compared with the 
aqueous extract. Care should therefore be taken in the 
use of the extracts.  
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